Letaplimab represents a novel medical method for addressing complement-mediated diseases. This antibody targets complement component C1q, a essential molecule of the complement cascade, potentially disrupt its initial https://oisihdsl668826.blogdigy.com/letaplimab-a-new-therapeutic-approach-65321163